The COVID-19 vaccine concerns scale: Development and validation of a new measure
Reasons for COVID-19 hesitancy are multi-faceted and tend to differ from those for general vaccine hesitancy. We developed the COVID-19 Vaccine Concerns Scale (CVCS), a self-report measure intended to better understand individuals’ concerns about COVID-19 vaccines. We validated the scale using data...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-11-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2022.2050105 |
| _version_ | 1827806493649403904 |
|---|---|
| author | Megan E. Gregory Sarah R. MacEwan Jonathan R. Powell Jaclyn Volney Jordan D. Kurth Eben Kenah Ashish R. Panchal Ann Scheck McAlearney |
| author_facet | Megan E. Gregory Sarah R. MacEwan Jonathan R. Powell Jaclyn Volney Jordan D. Kurth Eben Kenah Ashish R. Panchal Ann Scheck McAlearney |
| author_sort | Megan E. Gregory |
| collection | DOAJ |
| description | Reasons for COVID-19 hesitancy are multi-faceted and tend to differ from those for general vaccine hesitancy. We developed the COVID-19 Vaccine Concerns Scale (CVCS), a self-report measure intended to better understand individuals’ concerns about COVID-19 vaccines. We validated the scale using data from a convenience sample of 2,281 emergency medical services providers, a group of professionals with high occupational COVID-19 risk. Measures included the CVCS items, an adapted Oxford COVID-19 vaccine hesitancy scale, a general vaccine hesitancy scale, demographics, and self-reported COVID-19 vaccination status. The CVCS had high internal consistency reliability (α = .89). A one-factor structure was determined by exploratory and confirmatory factor analyses (EFA and CFA), resulting in a seven-item scale. The model had good fit (X2[14] = 189.26, p < .001; CFI = .95, RMSEA = .11 [.09, .12], NNFI = .93, SRMR = .03). Moderate Pearson correlations with validated scales of general vaccine hesitancy (r = .71 , p < .001; n = 2144) and COVID-19 vaccine hesitancy (r = .82; p < .001; n = 2279) indicated construct validity. The CVCS predicted COVID-19 vaccination status (B = −2.21, Exp(B) = .11 [95% CI = .09, .13], Nagelkerke R2 = .55), indicating criterion-related validity. In sum, the 7-item CVCS is a reliable and valid self-report measure to examine fears and concerns about COVID-19 vaccines. The scale predicts COVID-19 vaccination status and can be used to inform efforts to reduce COVID-19 vaccine hesitancy. |
| first_indexed | 2024-03-11T21:41:56Z |
| format | Article |
| id | doaj.art-a299527706b1474fbf5ad430210d7a7d |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T21:41:56Z |
| publishDate | 2022-11-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-a299527706b1474fbf5ad430210d7a7d2023-09-26T13:19:05ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2022-11-0118510.1080/21645515.2022.20501052050105The COVID-19 vaccine concerns scale: Development and validation of a new measureMegan E. Gregory0Sarah R. MacEwan1Jonathan R. Powell2Jaclyn Volney3Jordan D. Kurth4Eben Kenah5Ashish R. Panchal6Ann Scheck McAlearney7The Ohio State UniversityThe Ohio State UniversityNational Registry of Emergency Medical TechniciansThe Ohio State UniversityNational Registry of Emergency Medical TechniciansThe Ohio State University College of Public HealthThe Ohio State UniversityThe Ohio State UniversityReasons for COVID-19 hesitancy are multi-faceted and tend to differ from those for general vaccine hesitancy. We developed the COVID-19 Vaccine Concerns Scale (CVCS), a self-report measure intended to better understand individuals’ concerns about COVID-19 vaccines. We validated the scale using data from a convenience sample of 2,281 emergency medical services providers, a group of professionals with high occupational COVID-19 risk. Measures included the CVCS items, an adapted Oxford COVID-19 vaccine hesitancy scale, a general vaccine hesitancy scale, demographics, and self-reported COVID-19 vaccination status. The CVCS had high internal consistency reliability (α = .89). A one-factor structure was determined by exploratory and confirmatory factor analyses (EFA and CFA), resulting in a seven-item scale. The model had good fit (X2[14] = 189.26, p < .001; CFI = .95, RMSEA = .11 [.09, .12], NNFI = .93, SRMR = .03). Moderate Pearson correlations with validated scales of general vaccine hesitancy (r = .71 , p < .001; n = 2144) and COVID-19 vaccine hesitancy (r = .82; p < .001; n = 2279) indicated construct validity. The CVCS predicted COVID-19 vaccination status (B = −2.21, Exp(B) = .11 [95% CI = .09, .13], Nagelkerke R2 = .55), indicating criterion-related validity. In sum, the 7-item CVCS is a reliable and valid self-report measure to examine fears and concerns about COVID-19 vaccines. The scale predicts COVID-19 vaccination status and can be used to inform efforts to reduce COVID-19 vaccine hesitancy.http://dx.doi.org/10.1080/21645515.2022.2050105vaccine hesitancycovid-19scale developmentscale validationsurvey |
| spellingShingle | Megan E. Gregory Sarah R. MacEwan Jonathan R. Powell Jaclyn Volney Jordan D. Kurth Eben Kenah Ashish R. Panchal Ann Scheck McAlearney The COVID-19 vaccine concerns scale: Development and validation of a new measure Human Vaccines & Immunotherapeutics vaccine hesitancy covid-19 scale development scale validation survey |
| title | The COVID-19 vaccine concerns scale: Development and validation of a new measure |
| title_full | The COVID-19 vaccine concerns scale: Development and validation of a new measure |
| title_fullStr | The COVID-19 vaccine concerns scale: Development and validation of a new measure |
| title_full_unstemmed | The COVID-19 vaccine concerns scale: Development and validation of a new measure |
| title_short | The COVID-19 vaccine concerns scale: Development and validation of a new measure |
| title_sort | covid 19 vaccine concerns scale development and validation of a new measure |
| topic | vaccine hesitancy covid-19 scale development scale validation survey |
| url | http://dx.doi.org/10.1080/21645515.2022.2050105 |
| work_keys_str_mv | AT meganegregory thecovid19vaccineconcernsscaledevelopmentandvalidationofanewmeasure AT sarahrmacewan thecovid19vaccineconcernsscaledevelopmentandvalidationofanewmeasure AT jonathanrpowell thecovid19vaccineconcernsscaledevelopmentandvalidationofanewmeasure AT jaclynvolney thecovid19vaccineconcernsscaledevelopmentandvalidationofanewmeasure AT jordandkurth thecovid19vaccineconcernsscaledevelopmentandvalidationofanewmeasure AT ebenkenah thecovid19vaccineconcernsscaledevelopmentandvalidationofanewmeasure AT ashishrpanchal thecovid19vaccineconcernsscaledevelopmentandvalidationofanewmeasure AT annscheckmcalearney thecovid19vaccineconcernsscaledevelopmentandvalidationofanewmeasure AT meganegregory covid19vaccineconcernsscaledevelopmentandvalidationofanewmeasure AT sarahrmacewan covid19vaccineconcernsscaledevelopmentandvalidationofanewmeasure AT jonathanrpowell covid19vaccineconcernsscaledevelopmentandvalidationofanewmeasure AT jaclynvolney covid19vaccineconcernsscaledevelopmentandvalidationofanewmeasure AT jordandkurth covid19vaccineconcernsscaledevelopmentandvalidationofanewmeasure AT ebenkenah covid19vaccineconcernsscaledevelopmentandvalidationofanewmeasure AT ashishrpanchal covid19vaccineconcernsscaledevelopmentandvalidationofanewmeasure AT annscheckmcalearney covid19vaccineconcernsscaledevelopmentandvalidationofanewmeasure |